Related Experiment Video
Updated: Apr 18, 2026

Induction and Analysis of Epithelial to Mesenchymal Transition
Published on: August 27, 2013
KSR1 is coordinately regulated with Notch signaling and oxidative phosphorylation in thyroid cancer
Jandee Lee1, Mi-Youn Seol1, Seonhyang Jeong1
1Departments of SurgeryInternal MedicinePathologyYonsei Cancer Center, Severance Hospital, Yonsei University College of Medicine, 120-752 Seoul, Korea.
Abstract:
Kinase suppressor of RAS1 (KSR1) is a scaffold protein implicated in RAS-mediated RAF activation. However, the molecular function of KSR in papillary thyroid cancer (PTC) is unknown. Thus, this study aimed to characterize the role of KSR1 in patients with PTC. qRT-PCR and immunohistochemistry (IHC) revealed inter-tumor heterogeneities in the expression of KSR1 in PTC tissues. Interestingly, BRAFV600E-positive PTC showed higher KSR1 mRNA expression than BRAFV600E-negative PTC (P<0.001). Gene Set Enrichment Analysis (GSEA) using public repositories showed that high KSR1 expression coordinately upregulated Notch signaling (nominal P=0.019, false discovery rate (FDR) q-value=0.165); this finding was supported by GeneNetwork analysis, indicating that KSR1 expression is positively correlated with NOTCH1 expression (ρ=0.677, P=6.15×10(-9)). siRNA against KSR1 (siKSR1) significantly decreased ERK phosphorylation induced by BRAFV600E, resulting in reduced expression of NOTCH1 and HES1, targets of Notch signaling. GSEA revealed that high KSR1 expression was also associated with downregulation of genes related to oxidative phosphorylation (OxPhos). Consistent with this, electron microscopy showed that PTCs with high KSR1 expression exhibited structural defects of the mitochondrial cristae. Furthermore, siKSR1-transfected BCPAP and 8505C cells generated fewer colonies in colony-forming assays. In addition, GSEA showed that high expression of KSR2 and connector enhancer of KSR1 (CNKSR1) also coordinately upregulated Notch signaling (KSR2: nominal P=0.0097, FDR q-value=0.154 and CNKSR1: nominal P<0.0001, FDR q-value=0.00554), and high CNKSR2 was associated with downregulation of the OxPhos gene set (nominal P<0.0001, FDR q-value <0.0001). In conclusion, KSR1 is coordinately regulated with Notch signaling and OxPhos in PTC, because its scaffold function might be required to sustain the proliferative signaling and metabolic remodeling associated with this type of cancer.
Insights
Kinase suppressor of RAS1 (KSR1) plays a key role in papillary thyroid cancer (PTC) by upregulating Notch signaling and affecting mitochondrial oxidative phosphorylation. Targeting KSR1 may offer new therapeutic strategies for PTC.
Area of Science:
- Oncology
- Molecular Biology
- Cell Signaling
Background:
- Kinase suppressor of RAS1 (KSR1) is a scaffold protein involved in RAS-mediated RAF activation.
- The specific role of KSR1 in papillary thyroid cancer (PTC) has not been previously elucidated.
Purpose of the Study:
- To characterize the molecular function and significance of KSR1 in papillary thyroid cancer (PTC).
Main Methods:
- Quantitative real-time PCR (qRT-PCR) and immunohistochemistry (IHC) for KSR1 expression.
- Gene Set Enrichment Analysis (GSEA) and GeneNetwork analysis for pathway associations.
- siRNA-mediated KSR1 knockdown and subsequent molecular and cellular assays (e.g., ERK phosphorylation, Notch signaling targets, colony formation).
- Electron microscopy for mitochondrial structure analysis.
Main Results:
- KSR1 expression exhibits inter-tumor heterogeneity in PTC and is higher in BRAFV600E-positive tumors.
- High KSR1 expression correlates with upregulated Notch signaling and downregulated oxidative phosphorylation (OxPhos) genes.
- KSR1 knockdown reduces ERK phosphorylation, Notch signaling, and colony formation, while affecting mitochondrial structure.
Conclusions:
- KSR1 is coordinately regulated with Notch signaling and oxidative phosphorylation in PTC.
- KSR1's scaffold function may be crucial for sustaining proliferative signaling and metabolic reprogramming in PTC.
- These findings suggest KSR1 as a potential therapeutic target in PTC.
Related Concept Videos
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Notch Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
PI3K/mTOR/AKT Signaling Pathway

